13.05.2015
- In an interview with the British business daily Financial Times (FT), Andrew Witty, CEO of Glaxo SmithKline (GSK), has questioned the economics of the current wave of mergers and...
03.05.2013
- Gilead Sciences said on Thursday that its quarterly profit rose 63% as lower sales of its older HIV drugs were offset by strong sales of new products, but the results fell slightly...
27.02.2013
- GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor...
